Canadian lab extends diagnosis capacity:
This article was originally published in Clinica
Canada's National Microbiology Laboratory (NML) has received its second shipment of biosafety level 4 viruses. The delivery, from Maryland, US, includes more than a dozen reference virus strains. The NML, which specialises in diagnosis and research on what are billed by Health Canada as "some of the world's most dangerous infectious diseases", is located at the Canadian Science Centre for Human and Animal Health, in Winnipeg. The centre is the first facility in the world to accommodate both human and animal health facilities at the highest level of biocontainment, allowing researchers from both the NML and the National Centre for Foreign Animal Disease to collaborate on research into diseases affecting both humans and animals. The NML received its first shipment of biosafety level 4 viruses in June 2000.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.